AI Healthcare Stocks Rally as Illumina (ILMN.US) Surges Over 18% on Strong Earnings

Intelligent Finance APP learned that on Friday, AI healthcare concept stocks strengthened. Illumina (ILMN.US) surged over 18% after its earnings report, CRISPR Therapeutics (CRSP.US) rose over 6%, Hims & Hers Health (HIMS.US) increased by more than 5%, and Tempus AI (TEM.US), Teladoc Health (TDOC.US) climbed over 2%. In terms of news, Illumina achieved revenue and profits exceeding expectations in the third quarter. The adjusted earnings per share (EPS) was $1.34, surpassing the market expectation of $1.19 (an 18% year-over-year increase from last year’s $1.14). Revenue reached $1.084 billion, which, although flat year-over-year, still exceeded market expectations of $1.065 billion, thanks to accelerated growth in the clinical business segment, offsetting restrictions in the Chinese market and broader market headwinds.